Genetics




Nonimmune Fetal Hydrops



Listen




Definition




  • Presence of excess extracellular fluid in at least two fetal compartments (ascites, pleural effusion, pericardial effusion, skin edema, polyhydramnios) without any identifiable circulating antibody to red-cell antigens.
  • For a discussion on immune-mediated disease, see Chapter 37.
  • Prevalence is estimated at 1:1500-4000.
  • Highest prevalence in Southeast Asian population.




Conditions Associated with Nonimmune Fetal Hydrops



Listen




| Download (.pdf) | Print



























































Affected System


Approx. % of Cases (in third trimester)


Examples


Cardiac


20%


Fetal arrhythmias (bradyarrhythmias and tachyarrhythmias)


Structural cardiac defects causing congestive failure


Extrinsic compression of heart causing low output states → leads to fetal tachyarrhythmia → high-output failure → hydrops


Myocarditis


Renal


5%


Nephrosis


Renal hypoplasia/aplasia


Renal vein thrombosis


Obstructive uropathies


Infection


8%


Toxoplasmosis


Herpes simplex virus


Syphilis


Adenovirus


Rubella


CMV


Hepatitis


Parvovirus


Pulmonary


5%


Congenital chylothorax


Pulmonary lymphangiectasia


Congenital diaphragmatic hernia


Cystic adenomatoid malformations


Other intrathoracic masses (eg, pulmonary sequestration) that cause compression of thoracic blood vessels → obstructive venous flow → hydrops


Placenta/cord


Rare


Chorangioma


Arteriovenous malformation


Significant cord compression


Umbilical vein thrombosis


True umbilical cord knot


Maternal conditions


5%


Diabetes mellitus


Severe preeclampsia/ eclampsia


Hyperthyroidism


Gastrointestinal


5%


In utero midgut volvulus


Bowel atresias


Chromosomal


10%


Turner syndrome


Aneuploidy


Trisomies 13, 18, 21


Noonan Syndrome


Miscellaneous


10%


Congenital myopathies


Inborn errors of metabolism


CNS malformations


Skeletal dysplasias


Abdominal neoplasms


Unknown


20%





Diagnosis




  • Increased uterine size for dates
  • Decreased fetal movements
  • Generalized maternal edema (mirror syndrome)
  • Polyhydramnios (AFI >24)
  • Placentomegaly




Management




  • Infants with nonimmune hydrops are at very high risk for fetal demise.
  • Intrauterine therapy is aimed at treating underlying causes (maternal digitalis therapy for fetal tachyarrhythmias); if this is not possible, the risks of intrauterine death versus premature delivery have to be weighed.
  • By organ system (see table below).




Management of Nonimmune Fetal Hydrops by Organ System



Listen




| Download (.pdf) | Print





























System


Potential Difficulties/Management


Pulmonary



  • Difficult intubation due to severe edema of head/neck/oropharynx. → Consider ENT or anesthesia support for intubation as needed.
  • Varying degrees of pulmonary hypoplasia due to large pleural effusions or other extrinsic in utero compression of lungs → May need emergent thoracentesis in delivery area to alleviate lung compression from large effusions.
  • Chest tube placement for rapidly reaccumulating pleural effusions.

Cardiovascular



  • Hypotension should be treated with appropriate inotropic support.
  • Remember that most hydropic infants are euvolemic intravascularly, often with depressed cardiac function → Avoid large fluid shifts.
  • Pericardiocentesis may be necessary if cardiac tamponade from pericardial effusion is suspected → Should ideally be done under US guidance.
  • Arterial access is helpful to follow invasive blood pressures.
  • Echocardiogram should be obtained to evaluate for structural abnormalities as a cause of hydrops.

Fluids and electrolytes



  • Infants are total body fluid overloaded but are usually euvolemic (intravascular status).
  • Fluid intake should be based on a “dry” weight (ie, the 50th percentile for gestational age).
  • Fluids should be restricted (40–60 mL/kg/day) to avoid further fluid overload and to allow diuresis.


  • Vigilant attention to all fluid intake and output to maintain an adequate circulating volume.
  • Electrolyte losses should be replaced accordingly in the IV fluids.
  • Diuretics should be used very judiciously.
  • Abdominal US should be obtained to evaluate for an intra-abdominal mass/process that is compressing the IVC and other vascular structures.

Hematology



  • For infants who are very anemic (hematocrit <30%), an isovolumetric partial volume exchange transfusion should be done to raise the hematocrit to ∼40%–50% (see Chapter 37).
  • For management of immune-mediated disease, please refer to Chapter 37 for further discussion.

Infectious disease



  • Workup should proceed as indicated to find infectious etiologies for the infant’s hydrops.
  • Serum PCR can be sent to find evidence of a multitude of viral pathogens (enteroviruses, parvovirus, adenovirus, rubella).
  • Blood sample for viral cultures (for herpes simplex virus, CMV antigenemia).
  • Urine for CMV culture.
  • Serologies for bacterial or other pathogens as indicated.

Renal



  • Renal US to evaluate for intrinsic renal disease/obstructive uropathy as a cause of hydrops.
  • The role of ultrafiltration has not been established in the treatment of fluid overload found in hydropic infants, especially as the edema is known to improve with very careful monitoring of total fluid intake and output.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jan 9, 2019 | Posted by in PEDIATRICS | Comments Off on Genetics

Full access? Get Clinical Tree

Get Clinical Tree app for offline access